170 likes | 737 Views
Pharmacology . Pharmacokinetics Absorption Distribution Biotransformation (metabolism) Excretion Pharmacodynamics Receptor binding Signal transduction Physiologic effect. 59-291 Section 1, Lecture 3. Drug distribution.
E N D
Pharmacology • Pharmacokinetics • Absorption • Distribution • Biotransformation (metabolism) • Excretion • Pharmacodynamics • Receptor binding • Signal transduction • Physiologic effect
59-291 Section 1, Lecture 3 Drug distribution The transport of a drug in the body by the bloodstream to its site of action • Protein-binding • Water soluble vs. fat soluble • Blood-brain barrier • Areas of rapid distribution: heart, liver, kidneys, brain • Areas of slow distribution: muscle, skin, fat
-most drugs not uniformly distributed throughout the total body water -can be trapped in interstitial fluid or in plasma - if sufficiently lipophilic (hydrophobic) can get into cells Circulation cells Interstitial fluid
-maybe concentrated by ion trapping Consider a drug with a pKa= 2 pH =7.4 pH =2 HA H+ + A- -actively transported into liver cells and biotrnasformed -intestines drugs (anticancer) are pumped from blood to lumen and excreted by the body’s natural detoxifying mechanisms
Volume of Distribution Vd the volume of fluid in which drug would need to be dissolved in order to have the same concentration in that volume as it does in plasma V (L) PLASMA 4 INTERSTITIAL FLUID 10 INTERCELLULAT FLUID 28 Vd provides an indication of physiological distribution of a drug
If Vd = plasma volume or extracellular (interstitial) volume drug remains outside of cells (Plasma or interstitial fluid) If Vd = total body water drug is evenly distributed (ie ethanol) 500mg/ 11.9 mg/L= 42 L If Vd = >> total body water indicates drugs are concentrated in cells by ion trapping (500mg /2mg/L= 250L) Many weak bases have a large Vddue to intracellular ion trapping in the cells. Intracellular pH is less than Plasma pH >> weak bases are more in ionized from inside the cells
Factors Affecting Distribution • Organ blood flow • Brain, heart, liver, kidney > skeletal muscle > skin, adipose tissue • Plasma protein binding • Albumin; Drug binding to albumin ranges from 10% to 99% of plasma concentration • Alpha1 acid glycoprotein • Corticosteroid binding globulin • Alb-Drug Free drug Interstitial fluid, cells • Albumin (plasma protein) binding is saturable. What does this mean?? • Molecular size • High MW drugs stay only in plasma; Heparin • Lipid solubility • Blood Brain Barrier restricts the penetration of polar and ionized molecules into brain neurons
EXERCISE: A patient suffering from hyperalbumineuria requires 5 times the normal dose of an analgesic. Why? What kind of a Vd would you expect this patient to have for this analgesic?
Drug Biotransformation(Drug metabolism) • Enzyme-catalyzed conversion of drugs to their inactive metabolites, more soluble forms, or a more potent metabolite • Main purpose: To detoxify and inactive drugs and other foreign substances • Liver (main site), Kidneys, lungs, plasma, intestinal mucosa • Metabolites are usually more water soluble and excreted by kidneys • Prodrugs are biotransfomed to active drugs • Prodrug is absorbed better than biotransformed • First-pass biotransformation
First-pass effect Inactivates many drugs Alternatives: Rectal or sublingual
Phases of Drug transformation Phase I- create a chemical functional group on the drug that can be recognized by Phase-II enzymes. Product of phase I enzymes still have biological activity Phase II- no biological activity
Phase I Biotransformation • Oxidative reactions • Catalyzed by enzymes of microsomal fraction (ER) of liver • Microsomal cytochrome P450 monooxygenase • Hydrolytic reactions • Reductive reactions
Microsomal cytochrome P450 monooxygenase system is a family of enzymes that biotransforms many drugs Monooxygenase reaction